
Strong Jawlines & Shapely Necks: Optimizing Safe and Effective Treatment Options
This CE activity provides evidence-based education on lower face and neck rejuvenation, including anatomy-driven injection techniques, botulinum toxin, hyaluronic acid fillers, and energy-based devices. Participants will learn strategies for patient selection, treatment planning, and complication prevention to improve safety, outcomes, and confidence in aesthetic practice.
Target Audience
This activity is designed for an audience of physicians, physician assistants, nurse practitioners, nurses and other healthcare professionals.
Learning Objectives
Upon completion of the educational activity, participants should be able to:
- Define the most commonly reported aesthetic complications when treating jaw and neck line with non surgical aesthetic treatments.
- Relate and differentiate the techniques used in clinical trial design for jaw and neck line treatments and how these techniques may modify with real world experiences.
- Recall the manufacturing and property differences in the most popular fillers, neurotoxins and energy -based devices that are commonly used for jawline and neck treatments and how these may influence the way in which the particular aesthetic treatments are used safely.
- Describe when surgical treatments are the best option for obtaining an aesthetically pleasing neck and jawline.
Commerical Support
This activity is supported by an medical education grant from AbbVie Inc.
Disclosures
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.
All of the relevant financial relationships listed for these individuals have been mitigated.
Dorothy Caputo, MA BSN RN
Steven Dayan, MD
Sabrina Fabi, MD
Bernadette Maker, MSN, APRN-BC, NP-C
Rebecca Lakofsky, BSN, RN
Bernadette Maker, MSN, APRN-BC, NP-C
Steven Dayan, MD
Sabrina Fabi, MD
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Fabday LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit for learning and change.
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Credit being awarded: 1 ANCC contact hours
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Fabday LLC AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1 contact hour(s) (which includes 0 hour(s) of pharmacology).
Available Credit
- 1.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Fabday LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 1.00 contact hour(s) (which includes 0.00 hour(s) of pharmacology). - 1.00 AAPA Category 1 CME
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. - 1.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 1.00 ANCC Contact Hours
Credit being awarded: 1.00 ANCC contact hours
- 1.00 Attendance
Credits: 1.00
- 1.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price
Criteria for Success
A certificate of completion will be awarded based on the participant's attendance and completion of the online evaluation/claim credit form. If you have questions about this CE activity, please contact AKH Inc at [email protected].

Facebook
X
LinkedIn
Forward